[Policy Alert] Pre-Op Anesthesia Protocols Standardized Globally For Patients Taking Glp-1s

[Policy Alert] Pre-Op Anesthesia Protocols Standardized Globally For Patients Taking Glp-1s

[Policy Alert] Pre-Op Anesthesia Protocols Standardized Globally For Patients Taking Glp-1s

#Policy #Alert #PreOp #Anesthesia #Protocols #Standardized #Globally #Patients #Taking #Glps

161 GLP-1 Receptor Agonist Alert and All-New Consensus-Based Guidance by Anesthesia Patient Safety Foundation

Title: 161 GLP-1 Receptor Agonist Alert and All-New Consensus-Based Guidance
Channel: Anesthesia Patient Safety Foundation
[Case Study] Managing Post-Glp-1 Maintenance In Patients With Insulin Resistance And Pre-Diabetes

[Policy Alert] Pre-Op Anesthesia Protocols Standardized Globally For Patients Taking Glp-1s

The rapid rise of GLP-1 receptor agonists—such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound)—has revolutionized the management of type 2 diabetes and obesity. However, their widespread use has introduced a critical safety challenge in surgical settings: an increased risk of pulmonary aspiration under anesthesia.

To address this hazard, major anesthesia societies worldwide, including the American Society of Anesthesiologists (ASA) and the European Society of Anaesthesiology and Intensive Care (ESAIC), have established standardized global anesthesia standards for GLP-1s. These updated policies aim to balance glycemic control with patient safety during elective and urgent surgical procedures.


Why GLP-1 Receptor Agonists Present a Unique Anesthesia Challenge

GLP-1 receptor agonists work by mimicking incretin hormones to stimulate insulin secretion, lower glucagon levels, and delay gastric emptying. While highly effective for weight loss and blood sugar control, this delayed gastric clearance presents a direct conflict with traditional preoperative fasting guidelines.

The Mechanism: Delayed Gastric Emptying and Aspiration Risk

Traditional "NPO" (nothing by mouth) guidelines assume that a patient's stomach will empty clear liquids within two hours and solids within six to eight hours. GLP-1 receptor agonists disrupt this timeline.

  • The Danger of a "Full Stomach": Even after fasting for the standard 8 to 12 hours, patients on GLP-1 medications can still have significant amounts of undigested food in their stomachs.
  • Pulmonary Aspiration: During the induction of anesthesia, protective airway reflexes are lost. If gastric contents regurgitate into the pharynx, they can be inhaled into the lungs, causing aspiration pneumonia, respiratory failure, or death.

Clinical Example: A patient scheduled for an elective cholecystectomy fasts for 10 hours. Because they took their weekly semaglutide injection three days prior, delayed gastric emptying occurs. Upon induction of anesthesia, the patient experiences silent regurgitation of solid food, requiring immediate emergency airway management and intensive care admission.


The New Global Standards: Preoperative Management of GLP-1 Agonists

To mitigate these risks, international anesthesia consensus guidelines now dictate clear withholding protocols based on the dosing schedule of the medication and the nature of the surgery.

Guidelines for Elective Procedures (Withholding Protocols)

For patients scheduled for elective surgeries, the primary strategy is to temporarily pause the medication to allow gastric motility to return to normal.

  1. Weekly Dosing Regimens: For patients taking weekly injections (e.g., Ozempic, Wegovy, Mounjaro, Trulicity), hold the medication for one full week prior to the day of procedure. For example, if the patient’s last dose was on a Friday and surgery is scheduled for the following Thursday, the patient should skip the intervening Friday dose.
  2. Daily Dosing Regimens: For patients taking daily oral or injectable formulations (e.g., Rybelsus, Saxenda), hold the medication on the morning of the procedure.
  3. Coordination of Diabetes Care: If the GLP-1 agonist is withheld for patients with type 2 diabetes, anesthesiologists must coordinate with the patient's prescribing physician to monitor blood glucose levels and implement alternative bridging therapies (such as short-acting insulin) if necessary.

Guidelines for Urgent or Emergency Procedures

When a patient requires emergency surgery and has not withheld their GLP-1 medication, the clinical team must assume the patient has a "full stomach" regardless of their fasting duration.

  • Rapid Sequence Induction (RSI): Providers should utilize RSI with cricoid pressure to secure the airway rapidly and prevent aspiration.
  • Point-of-Care Ultrasound (POCUS): If the patient's fasting status or gastric volume is highly uncertain, clinicians are encouraged to perform a bedside gastric ultrasound to evaluate the stomach contents (empty, liquid, or solid) before proceeding with general anesthesia.
  • Alternative Anesthetic Techniques: Where feasible, regional anesthesia, local blocks, or peripheral nerve blocks should be prioritized over general anesthesia to preserve the patient's active airway reflexes.

Summary of Global Anesthesia Guidelines

The table below outlines the core recommendations from major international anesthesia societies regarding preoperative fasting and GLP-1 management:

| Association | Withholding Guideline (Weekly Dosing) | Withholding Guideline (Daily Dosing) | Management if Medication Was Not Held | | :--- | :--- | :--- | :--- | | American Society of Anesthesiologists (ASA) | Hold for 1 week prior to surgery | Hold on the day of surgery | Proceed as "full stomach" (use RSI, postpone if elective, or utilize gastric ultrasound) | | European Society of Anaesthesiology & Intensive Care (ESAIC) | Hold for 1 week prior to surgery | Hold on the day of surgery | Individualized assessment; consider gastric ultrasound; treat as high-risk airway | | Joint UK Consensus Group | Hold for 1 week prior to surgery | Hold on the day of surgery | Postpone elective cases if gastric symptoms (nausea, vomiting, bloating) are present |


Clinical Assessment and Pre-Op Screening Checklist for Providers

Surgical centers and pre-admission testing (PAT) clinics must update their intake procedures to screen specifically for GLP-1 therapies. Use this clinical checklist during pre-operative assessments:

  1. [ ] Identify the Drug: Ask patients explicitly if they take medications for weight loss or diabetes, specifically targeting brand names like Ozempic, Wegovy, Mounjaro, Zepbound, Rybelsus, Saxenda, or Victoza.
  2. [ ] Confirm Dosing Schedule: Document whether the medication is administered daily or weekly, along with the date and time of the last dose.
  3. [ ] Screen for GI Symptoms: Assess the patient for active gastrointestinal side effects, such as nausea, vomiting, bloating, abdominal pain, or severe constipation, which indicate active delayed gastric emptying.
  4. [ ] Evaluate Metabolic Status: For diabetic patients, review recent HbA1c levels and establish a perioperative blood glucose monitoring plan.
  5. [ ] Determine the Airway Strategy: If the medication was not held for the recommended duration, document the clinical decision to proceed (using RSI/ultrasound) or to postpone the elective procedure.

Patient Education: What to Tell Patients Prior to Surgery

Clear communication between surgical coordinators, pre-op nurses, and patients is vital to prevent last-minute cancellations or life-threatening complications.

  • Explain the "Why": Patients must understand that holding their medication is not about blood sugar control alone; it is a vital safety measure to prevent food or liquid from entering their lungs during surgery.
  • Provide Clear Written Instructions: Give patients precise dates detailing when to take their last dose and when to resume the medication post-surgery (typically the day after the procedure, provided they are tolerating oral intake).
  • Instruct on Symptom Reporting: Advise patients to notify the surgical team immediately if they experience unusual nausea, vomiting, or abdominal fullness in the days leading up to their procedure.

Conclusion: Balancing Glycemic Control with Patient Safety

The standardization of preoperative fasting GLP-1 protocols represents a major milestone in patient safety. By establishing uniform guidelines to hold these medications prior to anesthesia, clinical bodies have provided anesthesia teams with a clear roadmap to reduce aspiration risks. Implementing these protocols requires active collaboration between surgeons, anesthesiologists, endocrinologists, and patients to ensure that metabolic health is maintained without compromising safety in the operating room.

[Data Insight] 81% Of Patients Approved For Clinical Programs Report Long-Term Metabolic Improvement

160 Breaking Perioperative News GLP-1 Receptor Agonist Alert by Anesthesia Patient Safety Foundation

Title: 160 Breaking Perioperative News GLP-1 Receptor Agonist Alert
Channel: Anesthesia Patient Safety Foundation
[Data Insight] 81% Of Patients Approved For Clinical Programs Report Long-Term Metabolic Improvement

Manajemen peri-op pada orang dewasa yang mengonsumsi agonis reseptor GLP-1 by Learn with NUH

Title: Manajemen peri-op pada orang dewasa yang mengonsumsi agonis reseptor GLP-1
Channel: Learn with NUH

To Hold or Not to Hold GLP-1s Before Surgery by Medscape

Title: To Hold or Not to Hold GLP-1s Before Surgery
Channel: Medscape